Genes Tech Group Holdings Co (HKSE:08257) ROCE % : 6.63% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Genes Tech Group Holdings Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Genes Tech Group Holdings Co's annualized ROCE % for the quarter that ended in Dec. 2023 was 6.63%.

Genes Tech Group Holdings Co ROCE % Historical Data

The historical data trend for Genes Tech Group Holdings Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genes Tech Group Holdings Co ROCE % Chart

Genes Tech Group Holdings Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

36.10

21.62

12.42

-6.43

15.09

Genes Tech Group Holdings Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															-100.30	19.03	27.86	6.85	6.63

Genes Tech Group Holdings Co ROCE % Calculation

Genes Tech Group Holdings Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	36.454	/	( ( (630.738 - 394.24)	+	(525.514 - 278.949) )	/ 2 )
	=	36.454	/	( (236.498	+	246.565)	/ 2 )
	=	36.454	/	241.5315
	=	15.09 %

Genes Tech Group Holdings Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	16.356	/	( ( (0 - 0)	+	(525.514 - 278.949) )	/ 1 )
	=	16.356	/	( ( 0	+	246.565 )	/ 1 )
	=	16.356	/	246.565
	=	6.63 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Genes Tech Group Holdings Co (HKSE:08257) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Genes Tech Group Holdings Co ROCE % Related Terms

Thank you for viewing the detailed overview of Genes Tech Group Holdings Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genes Tech Group Holdings Co (HKSE:08257) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » Genes Tech Group Holdings Co Ltd (HKSE:08257) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 80, Baotai 3rd Road, Hsinchu County, Zhubei City, TWN, 30244

Website

http://www.genestech.com

Genes Tech Group Holdings Co Ltd is engaged in the business of Provision of turnkey solution and Trading of used semiconductor manufacturing equipment and parts. It generates prime revenue from the Provision of turnkey solution segment. The company offers turnkey solution of used SME and Parts to customers who need to alter and upgrade the semiconductors of production systems from time to time. The SME and parts supplied by the group include furnaces, clean tracks, and other related items, which are used at the front-end of the semiconductor manufacturing process, wafer fabrication, such as deposition, photoresist coating, and development. It has a business presence in Taiwan, the PRC, Singapore, the United States, Japan and other countries.

Genes Tech Group Holdings Co (HKSE:08257) Headlines

No Headlines